Non-irritating, non-blurring, photostable ophthalmic sunscreen composition
A non-irritation, non-blurring, photostable ophthalmic sunscreen composition contains at least one of the following: bemotrizinol; bisoctrizole; tris-biphenyl triazine; and/or octyl methoxycinnamate. A liquid vehicle base is then a remainder of the solution by weight. The composition is an artificial tear formulation or an ophthalmic suspension or ointment. The composition may include at least one inorganic and/or at least one organic active ingredient. The inorganic active ingredients may include, but not be limited to zinc oxide, titanium dioxide, iron oxide, zirconium oxide, and cerium oxide. The organic active ingredients may include, but not be limited to dioxybenzone, octinoxate, octisalate, homosalate, avobenzone, octocrylene, para-aminobenzoic acid, cinoxate, methyl anthranilate, octocrylene, padimate O, ensulizole, sulisobenzone, trolamine salicylate, and ecamsule.
1. A method of protecting an eye from ultraviolet radiation damage comprising administering to the ocular surface of the eye an ophthalmic sunscreen solution, comprising:
0.25 percent to 15 percent by weight of at least one of the following active agents:
bemotrizinol;
bisoctrizole; and
tris-biphenyl triazine;
and a liquid vehicle base, wherein the liquid vehicle base is an ophthalmic artificial tear formulation.
2. The method of claim 1 , wherein the ophthalmic sunscreen solution further comprises 0.25 percent to 15 percent by weight of an inorganic active ingredient.
3. The method of claim 2 , wherein the inorganic active ingredient is selected from the group consisting of titanium dioxide, zinc oxide, iron oxide, zirconium oxide, cerium oxide and mixtures thereof and wherein the inorganic active ingredient is in micronized form or nanoparticle form.
4. The method of claim 3 , wherein the ophthalmic sunscreen solution further comprises 0.25 percent to 15 percent by weight of an organic active ingredient and wherein the organic active ingredient is in micronized form or nanoparticle form.
5. The method of claim 4 , wherein the organic active ingredient is selected from the group consisting of dioxybenzone, octinoxate, octisalate, homosalate, avobenzone, octocrylene, para-aminobenzoic acid, cinoxate, methyl anthranilate, octocrylene, 2-ethylhexyl 4-(dimethylamino)benzoate, ensulizole, sulisobenzone, trolamine salicylate and ecamsule.
6. The method of claim 5 , wherein the ophthalmic sunscreen solution comprises 0.25 percent to 10 percent by weight of the at least one of the following active agents: bemotrizinol; bisoctrizole; and tris-biphenyl triazine.
7. The method of claim 5 , wherein the ophthalmic sunscreen solution comprises 0.25 percent to 5 percent by weight of the at least one of the following active agents: bemotrizinol; bisoctrizole; and tris-biphenyl triazine.
8. The method of claim 5 , wherein the liquid vehicle base is water-based or oil-based.
9. The method of claim 1 , wherein the ophthalmic sunscreen solution further comprises an emulsifier.
10. The method of claim 9 , wherein the emulsifier is selected from the group consisting of a silicone-based emulsifier, a polyethylene glycol emulsifier, a polysiloxane emulsifier, a glyscoside emulsifier, an acrylic-based emulsifier and combinations thereof.
11. The method of claim 9 , wherein the emulsifier comprises polysorbate, carbomer and/or castor oil.
12. The method of claim 1 , wherein the ophthalmic sunscreen solution further comprises an emollient.
13. The method of claim 12 , wherein the emollient is selected from the group consisting of aloe extracts, oleaginous esters, ethers and combinations thereof.
14. The method of claim 12 , wherein the emollient is an anhydrous lanolin and/or an oleaginous ingredient.
15. The method of claim 1 , wherein the ophthalmic sunscreen solution further comprises a preservative.
16. The method of claim 15 , wherein the preservative is an ionic-buffered preservative, a detergent or an oxidizing detergent.
17. The method of claim 1 , wherein the ophthalmic sunscreen solution further comprises a chelating agent.
18. The method of claim 1 , wherein the ophthalmic sunscreen solution further comprises an antioxidant.
19. The method of claim 1 , wherein the ophthalmic sunscreen solution further comprises an ophthalmic demulcent.
20. The method of claim 19 , wherein the ophthalmic demulcent is a cellulose derivative demulcent or a liquid polyol.
21. The method of claim 1 , further comprising a hypertonicity agent.
22. The method of claim 21 , wherein the hypertonicity agent is sodium chloride.
23. The method of claim 1 , further comprising an ophthalmic lubricant.
24. The method of claim 1 , further comprising an ophthalmic astringent.
25. The method of claim 1 , wherein the at least one of the following active agents: bemotrizinol; bisoctrizole; and tris-biphenyl triazine is in micronized or nanoparticle form.
26. The method of claim 1 , wherein the method does not cause blurred vision.